biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by frohlir944on Oct 01, 2018 7:05pm

121 Views

Post# 28725472

RE:Catherine and dr day

The only winners here are those buying right now, because the news is coming ( the story really hasn’t started yet, unfortunately deals and agreement news is dictated by the other parties)

Need I remind you we went to 2 dollars on fake news with poor management and an ill conceived business plan. Have you not noticed that we now have a stellar team executing a formidable plan designed to put this company into the most favorable position for a sale going forward.

Bullboard Posts

@ the Bell: TSX advances to start off Christmas trading week